We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVUE icon
51
Kenvue
KVUE
$36.9B
$28.9M 0.36%
1,588,358
+145,329
+10% +$2.82M
THS
52
DELISTED
Treehouse Foods
THS
$28.7M 0.36%
783,000
+85,000
+12% +$3.08M
K
53
DELISTED
Kellanova
K
$26M 0.33%
451,544
-126,376
-22% -$7.45M
DDOG icon
54
Datadog
DDOG
$95.4B
$25.8M 0.33%
199,183
+89,062
+81% +$10.8M
MGNX icon
55
MacroGenics
MGNX
$235M
$25.5M 0.32%
6,000,000
+3,600,000
+150% +$35.1M
BILL icon
56
BILL Holdings
BILL
$4.49B
$25.3M 0.32%
479,964
+145,901
+44% +$8.26M
CRL icon
57
Charles River Laboratories
CRL
$11.2B
$24.6M 0.31%
119,071
+49,189
+70% +$11.1M
PLNT icon
58
Planet Fitness
PLNT
$4.42B
$23.1M 0.29%
314,214
+79,943
+34% +$5.19M
XOM icon
59
ExxonMobil
XOM
$644B
$23.1M 0.29%
200,348
+11,048
+6% +$1.29M
SCLX icon
60
Scilex Holding
SCLX
$46.9M
$23.1M 0.29%
+341,429
New +$14.4M
TXRH icon
61
Texas Roadhouse
TXRH
$13.5B
$22.3M 0.28%
129,893
-38,887
-23% -$6.34M
AUTL
62
Autolus Therapeutics
AUTL
$397M
$21.8M 0.27%
6,250,000
+1,578,000
+34% +$6.81M
MSFT icon
63
Microsoft
MSFT
$3.45T
$21.6M 0.27%
48,258
-1,431
-3% -$604K
GOOGL icon
64
Alphabet (Google) Class A
GOOGL
$4.36T
$21.1M 0.27%
115,723
-24,856
-18% -$4.19M
AMZN icon
65
Amazon
AMZN
$2.92T
$21M 0.26%
108,794
-14,643
-12% -$2.69M
BMY icon
66
Bristol-Myers Squibb
BMY
$133B
$20.4M 0.26%
+490,868
New +$22M
ROST icon
67
Ross Stores
ROST
$80.5B
$19.9M 0.25%
137,000
+13,458
+11% +$1.86M
SXT icon
68
Sensient Technologies
SXT
$5.26B
$19.8M 0.25%
266,805
-112,195
-30% -$8.23M
EL icon
69
Estee Lauder
EL
$30.4B
$19.4M 0.24%
182,312
+96,239
+112% +$12.6M
UBER icon
70
Uber
UBER
$143B
$19.3M 0.24%
264,894
+71,598
+37% +$4.98M
ULTA icon
71
Ulta Beauty
ULTA
$22B
$18.5M 0.23%
47,959
+19,456
+68% +$7.91M
CHDN icon
72
Churchill Downs
CHDN
$5.88B
$17.3M 0.22%
124,254
+4,950
+4% +$650K
LOW icon
73
Lowe's Companies
LOW
$117B
$17.1M 0.21%
77,478
-10,313
-12% -$2.35M
VRTX icon
74
Vertex Pharmaceuticals
VRTX
$121B
$16.9M 0.21%
36,059
-15,921
-31% -$6.91M
XNCR icon
75
Xencor
XNCR
$1.5B
$16.4M 0.21%
864,000
-136,000
-14% -$2.92M

Similar funds

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.